NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Omniscient Neurotechnology

Omniscient Neurotechnology

Private
SydneyHealthcare & Life Scienceshttps://www.o8t.com/

Last Round

Series D

May 29, 2026

Est. Valuation

$295M

Total Funding Raised

$94.35M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Omniscient Neurotechnology is a healthcare technology company that offers a cloud-based connectomic analysis platform utilizing artificial intelligence to transform standard MRI scans into detailed brain network maps, facilitating the identification of neurological connections for improved patient care and predictive analytics.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

brain mappingconnectomicsneurosurgery softwareAI neurotechsurgical planningresting-state fMRIclinical decision supportbrain connectivity mapscurrent procedural terminologyCPTmedical imaging AIdigital brain atlasneuro-imagingsurgical navigation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Omniscient Neurotechnology Comps

Public and private peers based on sector, stage, and business model.

Omniscient Neurotechnology comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Omniscient Neurotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMay 29, 2026
Pre SeedApr 3, 2026
Series CJun 11, 2024
Series BJul 19, 2021
SeedJan 1, 2020

Key People

Founding team and executive leadership

Michael Sughrue

Founder And CMO

Founding Team

Stephen Scheeler

CEO

Executive Team

Adam Fraser

Chief Operating Officer

Executive Team

Bryan Sin

Chief Product Officer

Executive Team

Omniscient Neurotechnology Investors

Notable investors and investment history

Omniscient Neurotechnology investors
InvestorRounds
MS&AD VenturesPre Seed
Anamcara CapitalPre Seed
Plug and Play Tech CenterPre Seed
Drysdale VenturesPre Seed
xdeckPre Seed
National Reconstruction Fund CorporationSeries D
OIF VenturesSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 29, 2026

    $13.3M round completed.

  • Apr 15, 2026

    Neurological planning and visualization tool using resting-state fMRI has received FDA clearance.

Omniscient Neurotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Omniscient Neurotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Omniscient Neurotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney
Employee Range65
Year Founded2019
Last FundingMay 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.